Approved GLP-1 agonists include exenatide (Byetta, Bydureon), liraglutide (Victoza for diabetes, Saxenda for obesity), albiglutide (Tanzeum), dulaglutide (Trulicity), lixisenatide (Lyxumia in Europe, Adlyxin in the U.S.) and semaglutide (Ozempic, Rybelsus for diabetes, Wegovy for obesity)
The reason for these positive changes is thought to be modified VAF signaling to the brains VTA [42, 52] and the restoration of the correct sensitivity of the dopaminergic area to nutrients [53, 59] with changes in the hedonic processing of food intake [19]
Setria L-Glutathione is GRAS approved meaning it is safe for consumption
These medications work by mimicking naturally occurring incretin hormones, which slow gastric emptyingthe rate at which food moves from the stomach into the small intestine